Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
醫療保健板塊中最超賣的股票爲買入被低估的公司提供了機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI指標是一種動量指標，它比較了股票在價格上漲時的強度與在價格下跌時的強度。與股票的價格走勢進行比較，可以給交易者更好的了解股票短期內表現的良好程度。當RSI低於30時，資產通常被認爲是超賣的，根據Benzinga Pro的數據。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是本行業板塊最近的主要超賣股票列表，RSI接近或低於30。
Agilon Health Inc (NYSE:AGL)
紐交所上市的Agilon Health Inc (NYSE: AGL)
- On Aug. 6, Agilon Health reported worse-than-expected second-quarter revenue results and issued FY24 revenue guidance below estimates. "Our second quarter results were in-line with our guidance, and we are maintaining medical margin and Adjusted EBITDA guidance for the full year," said Steve Sell, chief executive officer. The company's stock fell around 37% over the past month and has a 52-week low of $4.38.
- RSI Value: 27.10
- AGL Price Action: Shares of Agilon Health fell 2.2% to close at $4.38 on Monday.
- Benzinga Pro's real-time newsfeed alerted to latest AGL news.
- 8月6日，Agilon Health報告了低於預期的第二季度營業收入結果，併發布了低於預期的FY24營業收入預測指引。「我們的第二季度結果與我們的指引一致，我們將保持全年的醫療保健邊際和調整後的EBITDA指引，」 首席執行官Steve Sell說道。該公司的股價在過去一個月內下跌了約37%，並且52周最低價爲$4.38。
- RSI數值：27.10
- AGL價格走勢：Agilon Health的股票週一下跌2.2%，收於$4.38。
- Benzinga Pro的實時新聞提醒了最新的AGL新聞。
Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
verrica製藥股票的納斯達克代碼爲VRCA
- On Aug. 14, Verrica Pharmaceuticals reported better-than-expected second-quarter financial results. The company also released preliminary results from Part 2 of its Phase 2 trial of VP-315 for basal cell carcinoma. The company's stock fell around 64% over the past month. It has a 52-week low of $2.53.
- RSI Value: 19.52
- VRCA Price Action: Shares of Verrica Pharmaceuticals fell 8.9% to close at $2.57 on Monday.
- Benzinga Pro's charting tool helped identify the trend in VRCA stock.
- 8月14日，verrica製藥公佈了超出預期的第二季度財務業績。該公司還發布了VP-315用於基底細胞癌的二期試驗第2部分的初步結果。該公司的股票在過去一個月內下跌了約64%。其52周最低價爲2.53美元。
- RSI指標值：19.52
- VRCA股價走勢：verrica製藥股票週一下跌了8.9%，收於2.57美元。
- Benzinga Pro的圖表工具幫助識別了VRCA股票的趨勢。
ALX Oncology Holdings Inc (NASDAQ:ALXO)
ALX Oncology Holdings Inc的納斯達克代碼爲ALXO
- On Aug. 8, ALX Oncology posted a narrower-than-expected quarterly loss. "Our team continues to make significant progress in the advancement of our evorpacept development pipeline across multiple oncology indications," said Jason Lettmann, Chief Executive Officer of ALX Oncology. The company's shares fell around 56% over the past month and has a 52-week low of $2.30.
- RSI Value: 28.48
- ALXO Price Action: Shares of ALX Oncology gained 7.5% to close at $2.57 on Monday.
- Benzinga Pro's signals feature notified of a potential breakout in ALXO shares.
- 8月8日，alx oncology發佈的季度虧損低於預期。alx oncology首席執行官Jason Lettmann表示：「我們的團隊在多個腫瘤病例中，在evorpacept開發項目中取得了重大進展。」該公司股票在過去一個月下跌了約56%，52周最低爲2.30美元。
- RSI數值：28.48
- ALX Oncology的股票價格表現：週一股價上漲7.5%，收於2.57美元。
Read More:
閱讀更多：
- Wall Street's Most Accurate Analysts Spotlight On 3 Industrials Stocks Delivering High-Dividend Yields
- 華爾街最準確的分析師聚焦3家工業股，提供高股息收益
譯文內容由第三人軟體翻譯。